Xylem (XYL)
(Delayed Data from NYSE)
$136.92 USD
+1.50 (1.11%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $136.85 -0.07 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Xylem (XYL) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$153.53 | $172.00 | $122.00 | 13.37% |
Price Target
Based on short-term price targets offered by 15 analysts, the average price target for Xylem comes to $153.53. The forecasts range from a low of $122.00 to a high of $172.00. The average price target represents an increase of 13.37% from the last closing price of $135.42.
Analyst Price Targets (15)
Broker Rating
Xylem currently has an average brokerage recommendation (ABR) of 1.68 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 19 brokerage firms. The current ABR compares to an ABR of 1.72 a month ago based on 18 recommendations.
Of the 19 recommendations deriving the current ABR, 12 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 63.16% and 5.26% of all recommendations. A month ago, Strong Buy made up 61.11%, while Buy represented 5.56%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/XYL.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 12 | 12 | 11 | 11 | 11 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.68 | 1.68 | 1.72 | 1.72 | 1.72 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/13/2024 | UBS | Damian Karas | Not Available | Strong Buy |
7/31/2024 | Robert W. Baird & Co. | Michael P Halloran | Strong Buy | Strong Buy |
6/4/2024 | Atlantic Equities | Richard Radbourne | Strong Buy | Strong Buy |
5/29/2024 | Argus Research Corp. | John M Eade | Not Available | Strong Buy |
5/8/2024 | Seaport Research Partners | Scott Graham | Hold | Hold |
5/3/2024 | Mizuho SecuritiesUSA | Brett Linzey | Hold | Hold |
5/3/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
5/2/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/18/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/8/2024 | Not Identified | Not Identified | Hold | Hold |
4/1/2024 | Cowen & Co. | Joseph Giordano | Strong Buy | Strong Buy |
3/31/2024 | Goldman Sachs | Brian K Lee | Strong Buy | Strong Buy |
3/27/2024 | Northcoast Research | Ryan M Connors | Hold | Hold |
3/12/2024 | Exane BNP Paribas | Andrew E Buscaglia | Not Available | Strong Buy |
1/4/2024 | Raymond James | Pavel S Molchanov | Strong Sell | Hold |
10/2/2023 | Not Identified | Not Identified | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.68 |
ABR (Last week) | 1.68 |
# of Recs in ABR | 19 |
Average Target Price | $153.53 |
LT Growth Rate | 13.30% |
Industry | Manufacturing - General Industrial |
Industry Rank by ABR | 183 of 253 |
Current Quarter EPS Est: | 1.11 |